Jung-Mo Ahn

City:

Richardson, Texas

Country:

United States

Published Applications:

Last publication date:

2016-05-12

Top Assignees for applications by Jung-Mo Ahn

The entities that hold a legal rights for patent applications filed by inventor Ahn Jung-Mo:

Board of Regents, The University of Texas System 8 Austin, TX United States
The Board of Regents of the University of Texas System 1 Austin, TX United States
New England Medical Center Hospitals, Inc. 1 Boston, MA United States
The Board of Regents of the University of Texas Systems 1 Austin, TX United States
TUFTS MEDICAL CENTER 1 Boston, MA United States
Board of Regents, The University System 1 Austin, TX United States

Recent patent applications by Ahn Jung-Mo

Jung-Mo Ahn from Richardson, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-05-12

US20160130217A1

Chemistry; metallurgy

Oligo-benzamide compounds and their use

#2 | 2014-05-08

US20140127285A1

Chemistry; metallurgy

Composition and method for making oligo-benzamide compounds

#3 | 2013-09-05

US20130231385A1

Chemistry; metallurgy

OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE

#4 | 2013-01-10

US20130011465A1

Chemistry; metallurgy

COMPOSITION AND METHOD FOR THE TREATMENT OF DISEASES AFFECTED BY APOPTOSIS

#5 | 2012-04-26

US20120100070A1

Human necessities

Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

#6 | 2010-12-16

US20100317570A1

Chemistry; metallurgy

Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor

#7 | 2010-07-15

US20100178324A1

Chemistry; metallurgy

Composition and method for the treatment of diseases affected by apoptosis

#8 | 2009-01-08

US20090012141A1

Chemistry; metallurgy

Composition and method for making oligo-benzamide compounds

#9 | 2008-12-25

US20080318844A1

Chemistry; metallurgy

Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

#10 | 2008-12-04

US20080300193A1

Chemistry; metallurgy

Composition and method for the treatment of diseases affected by a peptide receptor

InventorID:

27254 ⎘